Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Gozzetti

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
Haematologica|September 7, 2014
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infectionMaria R Ambrosio, Giulia De Falco, Alessandro Gozzetti, et al.
Tumori|December 12, 2013
Cost of illness in patients with multiple myeloma in Italy: the CoMiM studyMaria Teresa Petrucci, Elisabetta Calabrese, Anna Levi, et al.
Clinical Hematology International|October 1, 2021
Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?Anna Suska, David H Vesole, Jorge J Castillo, et al.
British Journal of Haematology|May 15, 2009
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factorsDavide Rossi, Elisa Sozzi, Alessia Puma, et al.
Oncotarget|August 17, 2016
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patientsMonica Bocchia, Sara Galimberti, Lara Aprile, et al.
The New England Journal of Medicine|April 11, 2025
Targetable Mutations in <i>BRAF</i> V600E-Negative Hairy-Cell LeukemiaAlessia Santi, Alessandra Venanzi, Alessandra Pucciarini, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event resultsAntonio Palumbo, Patrizia Falco, Antonietta Falcone, et al.
Leukemia & Lymphoma|November 26, 2021
Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomesLaurent Garderet, Mohammad Al Hariri, Joanna Wasielica-Poslednik, et al.
Journal of Clinical Medicine|February 27, 2026
Left Atrial Strain Correlation with Functional Capacity and Additional Prognostic Value of Speckle Tracking in Cardiac Amyloidosis: A Prospective, Single-Center StudyMaria Concetta Pastore, Marta Focardi, Federica Marrese, et al.
Frontiers in Oncology|May 14, 2023
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma NetworkElisabetta Antonioli, Sofia Pilerci, Irene Attucci, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Haematologica|September 7, 2014
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infectionMaria R Ambrosio, Giulia De Falco, Alessandro Gozzetti, et al.
Tumori|December 12, 2013
Cost of illness in patients with multiple myeloma in Italy: the CoMiM studyMaria Teresa Petrucci, Elisabetta Calabrese, Anna Levi, et al.
Clinical Hematology International|October 1, 2021
Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?Anna Suska, David H Vesole, Jorge J Castillo, et al.
British Journal of Haematology|May 15, 2009
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factorsDavide Rossi, Elisa Sozzi, Alessia Puma, et al.
Oncotarget|August 17, 2016
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patientsMonica Bocchia, Sara Galimberti, Lara Aprile, et al.
The New England Journal of Medicine|April 11, 2025
Targetable Mutations in <i>BRAF</i> V600E-Negative Hairy-Cell LeukemiaAlessia Santi, Alessandra Venanzi, Alessandra Pucciarini, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event resultsAntonio Palumbo, Patrizia Falco, Antonietta Falcone, et al.
Leukemia & Lymphoma|November 26, 2021
Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomesLaurent Garderet, Mohammad Al Hariri, Joanna Wasielica-Poslednik, et al.
Journal of Clinical Medicine|February 27, 2026
Left Atrial Strain Correlation with Functional Capacity and Additional Prognostic Value of Speckle Tracking in Cardiac Amyloidosis: A Prospective, Single-Center StudyMaria Concetta Pastore, Marta Focardi, Federica Marrese, et al.
Frontiers in Oncology|May 14, 2023
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma NetworkElisabetta Antonioli, Sofia Pilerci, Irene Attucci, et al.
Pageof 22